G1 Therapeutics, Inc.
Morphic forms of G1T38 and methods of manufacture thereof
Last updated:
Abstract:
This invention provides an unexpectedly stable, highly crystalline form of the di-HCl salt of ##STR00001## for advantageous therapeutic pharmaceutical efficacy and dosage form stability.
Status:
Grant
Type:
Utility
Filling date:
19 Dec 2019
Issue date:
1 Mar 2022